Spots Global Cancer Trial Database for A Study of Belantamab Mafodotin in Multiple Myeloma Participants With Normal and Impaired Hepatic Function
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of Belantamab Mafodotin in Multiple Myeloma Participants With Normal and Impaired Hepatic Function
Official Title: A Phase I Study to Evaluate the Pharmacokinetics and Safety of Belantamab Mafodotin Monotherapy in Participants With Relapsed or Refractory Multiple Myeloma Who Have Normal and Varying Degrees of Impaired Hepatic Function (DREAMM 13)
Study ID: NCT04398680
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to assess the pharmacokinetics (PK), safety, and tolerability of belantamab mafodotin monotherapy in Relapsed/Refractory Multiple Myeloma (RRMM) participants with impaired hepatic function and in matched RRMM participants with normal hepatic function.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
GSK Investigational Site, Tucson, Arizona, United States
GSK Investigational Site, Beverly Hills, California, United States
GSK Investigational Site, Plantation, Florida, United States
GSK Investigational Site, Chicago, Illinois, United States
GSK Investigational Site, Wichita, Kansas, United States
GSK Investigational Site, Baltimore, Maryland, United States
GSK Investigational Site, Hackensack, New Jersey, United States
GSK Investigational Site, Monroeville, Pennsylvania, United States
GSK Investigational Site, The Woodlands, Texas, United States
GSK Investigational Site, Milwaukee, Wisconsin, United States
GSK Investigational Site, Athens, , Greece
GSK Investigational Site, Athens, , Greece
GSK Investigational Site, Busan, , Korea, Republic of
GSK Investigational Site, Busan, , Korea, Republic of
GSK Investigational Site, Daegu, , Korea, Republic of
GSK Investigational Site, Hwasun, , Korea, Republic of
GSK Investigational Site, Incheon, , Korea, Republic of
GSK Investigational Site, Jeonju-si, , Korea, Republic of
GSK Investigational Site, Seoul, , Korea, Republic of
GSK Investigational Site, Seoul, , Korea, Republic of
GSK Investigational Site, Seoul, , Korea, Republic of
GSK Investigational Site, Suwon-si, Gyeonggi-do, , Korea, Republic of
Contact Details
Name: GSK Clinical Trials
Affiliation: GlaxoSmithKline
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
